109 related articles for article (PubMed ID: 11713209)
1. Regulation of Id2 gene expression by the type 1 IGF receptor and the insulin receptor substrate-1.
Navarro M; Valentinis B; Belletti B; Romano G; Reiss K; Baserga R
Endocrinology; 2001 Dec; 142(12):5149-57. PubMed ID: 11713209
[TBL] [Abstract][Full Text] [Related]
2. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
Mur C; Arribas M; Benito M; Valverde AM
Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
[TBL] [Abstract][Full Text] [Related]
3. Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells.
Valentinis B; Navarro M; Zanocco-Marani T; Edmonds P; McCormick J; Morrione A; Sacchi A; Romano G; Reiss K; Baserga R
J Biol Chem; 2000 Aug; 275(33):25451-9. PubMed ID: 10846175
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells.
Sun H; Baserga R
Endocrinology; 2004 Nov; 145(11):5332-43. PubMed ID: 15297443
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling by phosphatidylinositol 3-kinase.
Belletti B; Prisco M; Morrione A; Valentinis B; Navarro M; Baserga R
J Biol Chem; 2001 Apr; 276(17):13867-74. PubMed ID: 11278691
[TBL] [Abstract][Full Text] [Related]
6. The role of the insulin receptor substrate-1 in the differentiation of rat hippocampal neuronal cells.
Morrione A; Navarro M; Romano G; Dews M; Reiss K; Valentinis B; Belletti B; Baserga R
Oncogene; 2001 Aug; 20(35):4842-52. PubMed ID: 11521195
[TBL] [Abstract][Full Text] [Related]
7. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Id gene expression by type I insulin-like growth factor: roles of Stat3 and the tyrosine 950 residue of the receptor.
Prisco M; Peruzzi F; Belletti B; Baserga R
Mol Cell Biol; 2001 Aug; 21(16):5447-58. PubMed ID: 11463827
[TBL] [Abstract][Full Text] [Related]
9. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
[TBL] [Abstract][Full Text] [Related]
11. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
12. Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.
Byron SA; Horwitz KB; Richer JK; Lange CA; Zhang X; Yee D
Br J Cancer; 2006 Nov; 95(9):1220-8. PubMed ID: 17043687
[TBL] [Abstract][Full Text] [Related]
13. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2.
Sun H; Tu X; Prisco M; Wu A; Casiburi I; Baserga R
Mol Endocrinol; 2003 Mar; 17(3):472-86. PubMed ID: 12554758
[TBL] [Abstract][Full Text] [Related]
15. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
16. Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance.
Liu YF; Herschkovitz A; Boura-Halfon S; Ronen D; Paz K; Leroith D; Zick Y
Mol Cell Biol; 2004 Nov; 24(21):9668-81. PubMed ID: 15485932
[TBL] [Abstract][Full Text] [Related]
17. Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases.
Dews M; Prisco M; Peruzzi F; Romano G; Morrione A; Baserga R
Endocrinology; 2000 Apr; 141(4):1289-300. PubMed ID: 10746631
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
Batty IH; Fleming IN; Downes CP
Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
[TBL] [Abstract][Full Text] [Related]
19. Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1.
Sciacca L; Prisco M; Wu A; Belfiore A; Vigneri R; Baserga R
Endocrinology; 2003 Jun; 144(6):2650-8. PubMed ID: 12746329
[TBL] [Abstract][Full Text] [Related]
20. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
